A. . Rafeh Naqash, L. V. . Yang, E. J. . Sanderlin, D. C. . Atwell, and P. R. . Walker, “Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report”, AO, vol. 57, no. 5, pp. 705–708, May 2018.